Pharmaceutical Companies face a competitive challenge. Counterfeit Medicines. The fake medicine market is estimated to be worth £200bn per annum. For the Pharmaceutical firms this is lost revenue, and potential damaging to their reputations. The World Health Organisation estimates the number of deaths per annum as the result of taking fake malaria tablets to be 100,000 alone.

Contacts within the Pharmaceutical Market include Senior Clinical Trial Management, ICT experts, retail Pharmacy experts, a former CEO and directors at organisations specialising in combating fake medicines.